BIO Stock Overview
Develops, commercializes, and markets various live biotherapeutics and complimentary medicines in Australia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Biome Australia Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.47 |
| 52 Week High | AU$0.52 |
| 52 Week Low | AU$0.072 |
| Beta | 1.62 |
| 11 Month Change | 56.67% |
| 3 Month Change | 38.24% |
| 1 Year Change | 487.50% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 291.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIO | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | 27.0% | 11.7% | 0.8% |
| 1Y | 487.5% | 18.0% | 10.3% |
Return vs Industry: BIO exceeded the Australian Personal Products industry which returned 18% over the past year.
Return vs Market: BIO exceeded the Australian Market which returned 10.3% over the past year.
Price Volatility
| BIO volatility | |
|---|---|
| BIO Average Weekly Movement | 12.8% |
| Personal Products Industry Average Movement | 5.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in AU Market | 16.1% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: BIO's share price has been volatile over the past 3 months.
Volatility Over Time: BIO's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 30 | Blair William Brabin Norfolk | www.biomeaustralia.com |
Biome Australia Limited develops, commercializes, and markets various live biotherapeutics and complimentary medicines in Australia and internationally. It provides live biotherapeutic products under the Activated Probiotics brand; organic nutraceutical products under the Activated Nutrients brand; and sports performance and recovery products under the Activated X Performance brand. The company markets its products through community pharmacies, independent health practitioners, and health professionals.
Biome Australia Limited Fundamentals Summary
| BIO fundamental statistics | |
|---|---|
| Market cap | AU$100.09m |
| Earnings (TTM) | -AU$2.86m |
| Revenue (TTM) | AU$9.87m |
10.2x
P/S Ratio-35.3x
P/E RatioIs BIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIO income statement (TTM) | |
|---|---|
| Revenue | AU$9.87m |
| Cost of Revenue | AU$3.96m |
| Gross Profit | AU$5.91m |
| Other Expenses | AU$8.77m |
| Earnings | -AU$2.86m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 59.83% |
| Net Profit Margin | -29.03% |
| Debt/Equity Ratio | 52.3% |
How did BIO perform over the long term?
See historical performance and comparison